Rogers Campbell has submitted a Form 144 to sell 23,933 shares of Heartflow, Inc., valued at approximately $1.32 million. This filing, dated October 22, 2026, is significant as it reflects ongoing insider transactions within the company and highlights the activity in the surgical and medical instruments sector.
Heartflow, Inc. is a company that specializes in surgical and medical instruments and apparatus. The company is based in San Francisco, California, and operates under the SEC File Number 001-42790. The recent filing is part of a series of transactions by Campbell, who is an officer at Heartflow.
According to the filing, Campbell exercised stock options to acquire shares before selling them. Specifically, he acquired 6,503 shares on March 1, 2021, and an additional 17,430 shares on the same day as the sale. The filing also notes that Campbell has sold shares in the past three months, including 9,219 shares on August 17, 2026, and 13,179 shares on September 18, 2026.
This insider selling may affect investor sentiment regarding Heartflow and could influence trading activity in the surgical and medical instruments sector. The filing indicates that Campbell's transactions are part of a broader trend of insider selling, which can sometimes signal a company's internal dynamics or market conditions.
Details were not available in the SEC filing regarding any future plans or additional transactions by Campbell. Investors and analysts will be watching closely to see how this insider activity impacts Heartflow's market performance and investor confidence.